Skip to main content Skip to navigation
We care about your privacy. Read about your rights and how we protect your data. Get Details

Genetics Expert Talks about Tensions Between Parents and Regulators over Duchenne Treatments

October 30, 2014

In a long feature story about the regulatory, economic, and personal impact of Duchenne muscular dystrophy, Eric Hoffman, PhD, Children's Research Institute, discusses the current tension that exists between families, wanting access to treatments and clinical trials, and the FDA.